{"schema_version":"1","generated_at":"2026-10-28T13:56:09.979Z","data_as_of":"2026-10-23","url":"https://www.findmykol.com/kol/judith-aberg","json_url":"https://www.findmykol.com/kol/judith-aberg/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"judith-aberg","name":"Judith Aberg","credential":"MD","title":"Professor Emeritus, Medicine, Infectious Diseases","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"institution":"Icahn School of Medicine at Mount Sinai","institution_url":"https://www.findmykol.com/institution/icahn-school-of-medicine-at-mount-sinai","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1902969645","orcid":"0000-0001-8162-0284","openalex":"A5088973456"},"summary":"Judith Aberg is Professor Emeritus, Medicine, Infectious Diseases at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 376 publications with 23,354 citations (h-index 73); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the FindMyKOL directory.","overview":{"text":"Judith A. Aberg, M.D., is Professor Emeritus, Medicine, Infectious Diseases at Icahn School of Medicine at Mount Sinai. The public record shows 376 publications with 23,354 citations (h-index 73), centered on HIV-related health complications and treatments, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 7 companies, 5 NIH-funded awards (2004–2014).","bullets":["Most recent indexed publication: 2026 · Open forum infectious diseases","Top research focus: HIV-related health complications and treatments","11 registered trials on ClinicalTrials.gov","Open Payments reporting from 7 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"HIV","therapeutic_area":"Infectious Disease","trials":11,"topics":4,"strength":37},{"label":"HIV Infections","therapeutic_area":"Infectious Disease","trials":8,"topics":0,"strength":24},{"label":"Dyslipidemia / Lipid Disorders","therapeutic_area":"Cardiology","trials":2,"topics":1,"strength":7},{"label":"Lipodystrophy","therapeutic_area":"Endocrinology/Metabolic","trials":2,"topics":0,"strength":6},{"label":"Mycobacterium avium-intracellulare Infection","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Dyslipidemias","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Hypertriglyceridemia","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Atrophy","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Pneumonia","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Sexually Transmitted Diseases","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Pneumonia, Pneumocystis","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Cysts","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["HIV-related health complications and treatments","HIV/AIDS Research and Interventions","HIV/AIDS drug development and treatment","HIV Research and Treatment","Lipoproteins and Cardiovascular Health"],"drugs_studied":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"Egrifta","generic":"Tesamorelin","trials":0,"payments":2,"publications":0,"mentions":2},{"name":"Trogarzo","generic":"Ibalizumab","trials":0,"payments":2,"publications":0,"mentions":2},{"name":"Dovato","generic":"Dolutegravir / lamivudine","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":11,"shown":3,"withheld":8,"rows":[{"name":"Merck Sharp & Dohme LLC","trials":0,"payments":7,"mentions":7},{"name":"National Institute of Allergy and Infectious Diseases (NIAID)","trials":6,"payments":0,"mentions":6},{"name":"ViiV Healthcare Company","trials":0,"payments":4,"mentions":4}]}},"scholarship":{"works_count":376,"cited_by_count":23354,"h_index":73,"i10_index":195,"pubmed_count":28,"latest_activity_year":2026,"citation_standing":{"top_percent":5,"cohort":"Infectious Disease","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":11,"shown":3,"withheld":8,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT02155985","title":"Modulation of Immune Activation by Aspirin","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","source_url":"https://clinicaltrials.gov/study/NCT02155985","trial_url":"https://www.findmykol.com/trial/NCT02155985"},{"nct":"NCT01695954","title":"Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz","phase":"PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"NYU Langone Health","source_url":"https://clinicaltrials.gov/study/NCT01695954","trial_url":"https://www.findmykol.com/trial/NCT01695954"},{"nct":"NCT01351025","title":"Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","source_url":"https://clinicaltrials.gov/study/NCT01351025","trial_url":"https://www.findmykol.com/trial/NCT01351025"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":2025},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":4417.5,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902969645"},{"payer":"Theratechnologies Inc.","program_year":2025,"amount_usd":86.27,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902969645"},{"payer":"Invivyd Inc","program_year":2024,"amount_usd":1750,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902969645"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1902969645","source":"payments"},"prescribing":{"data_year":2019,"areas_total":1,"areas_shown":1,"areas":[{"area":"Nervous system","share_pct":100,"classes_total":1,"classes":[{"class":"gamma-Aminobutyric Acid A Receptor Positive Modulator","setting":"prescribed","share_pct":100,"drugs":[{"name":"Zolpidem Tartrate","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"funding":{"award_count":5,"fiscal_years":{"first":2004,"last":2014},"rows_total":101,"shown":3,"withheld":98,"rows":[{"project":"UM1AI069532","title":"New York University HIV/AIDS Clinical Trial Unit","fiscal_year":2014,"amount_usd":67226,"organization":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/UM1AI069532"},{"project":"UM1AI069532","title":"New York University HIV/AIDS Clinical Trial Unit","fiscal_year":2013,"amount_usd":1344582,"organization":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/UM1AI069532"},{"project":"UM1AI069532","title":"New York University HIV/AIDS Clinical Trial Unit","fiscal_year":2012,"amount_usd":1460503,"organization":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/UM1AI069532"}],"source":"grants"},"publications":{"total":28,"shown":5,"withheld":23,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis.","year":2026,"journal":"Open forum infectious diseases","types":["Clinical Trial","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42699213/","status":"verified"},{"title":"Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.","year":2026,"journal":"Open forum infectious diseases","types":["Clinical Trial","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42483033/","status":"verified"},{"title":"A tool based on objective data to identify patients at elevated risk of hospital-onset Staphylococcus aureus bacteremia: a nested case-control study.","year":2026,"journal":"Antimicrobial stewardship & healthcare epidemiology : ASHE","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42038617/","status":"verified"},{"title":"Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).","year":2026,"journal":"Circulation. Heart failure","types":["Journal Article","Randomized Controlled Trial","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41457980/","status":"verified"},{"title":"Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial.","year":2026,"journal":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","types":["Journal Article","Randomized Controlled Trial","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40576558/","status":"verified"}],"most_cited":{"total":376,"shown":5,"withheld":371,"rows":[{"title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","year":2020,"cited_by_count":2598,"type":"article","source_url":"https://doi.org/10.1038/s41591-020-1051-9"},{"title":"Robust neutralizing antibodies to SARS-CoV-2 infection persist for months","year":2020,"cited_by_count":1193,"type":"article","source_url":"https://doi.org/10.1126/science.abd7728"},{"title":"Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection","year":2023,"cited_by_count":848,"type":"article","source_url":"https://doi.org/10.1001/jama.2023.8823"},{"title":"Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America","year":2009,"cited_by_count":837,"type":"article","source_url":"https://doi.org/10.1086/605292"},{"title":"AKI in Hospitalized Patients with COVID-19","year":2020,"cited_by_count":803,"type":"article","source_url":"https://doi.org/10.1681/asn.2020050615"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Carl J. Fichtenbaum","coauthored_works":75},{"name":"Steven Kyle Grinspoon","coauthored_works":67},{"name":"Markella V. Zanni","coauthored_works":66}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/judith-aberg-md","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, Pennsylvania State University (medical degree)","source_url":"https://profiles.mountsinai.org/judith-a-aberg","status":"verified","collected_at":"2026-10-26"},{"value":"MD","source_url":"https://www.idsociety.org/about-us/awards/the-walter-e.-stamm-mentor-award/judith-a.-aberg-md-fidsa","status":"verified","collected_at":"2026-10-26"}]},"roles":{"total":5,"shown":3,"rows":[{"value":"Service on the IDSA Board of Directors, 2013-2016","source_url":"https://www.idsociety.org/about-us/awards/the-walter-e.-stamm-mentor-award/judith-a.-aberg-md-fidsa","status":"verified","collected_at":"2026-10-26"},{"value":"Chair, HIV Medicine Association (HIVMA), 2011-2012","source_url":"https://www.idsociety.org/about-us/awards/the-walter-e.-stamm-mentor-award/judith-a.-aberg-md-fidsa","status":"verified","collected_at":"2026-10-26"},{"value":"Editorial board member, three infectious disease journals (journals not named)","source_url":"https://profiles.mountsinai.org/judith-a-aberg","status":"verified","collected_at":"2026-10-26"}]},"awards":{"total":2,"shown":2,"rows":[{"value":"Walter E. Stamm Mentor Award, IDSA (2025)","source_url":"https://www.idsociety.org/about-us/awards/the-walter-e.-stamm-mentor-award/judith-a.-aberg-md-fidsa","status":"verified","collected_at":"2026-10-26"},{"value":"Honored by the IDSA Foundation, Women in ID (year not stated; article dated December 18, 2018)","source_url":"https://infectiousdiseases.wustl.edu/prior-id-fellow-dr-judy-aberg-honored-by-the-idsa-foundation-women-in-id/","status":"provisional","collected_at":"2026-10-26"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Infection Prevention and Infectious Diseases Expert, Mount Sinai Health System Emergency Operations Center","source_url":"https://profiles.mountsinai.org/judith-a-aberg","status":"verified","collected_at":"2026-10-26"}]},"media":{"total":1,"shown":1,"rows":[{"value":"IAS USA video presentation, \"Aging With HIV: I've Fallen But I Can Get Back Up\" (2019)","source_url":"https://www.iasusa.org/2019/05/29/aging-with-hiv-ive-fallen-but-i-can-get-back-up/","status":"provisional","collected_at":"2026-10-26"}]},"public_positions":{"total":2,"shown":2,"rows":[{"value":"Served on panels for the New York State Department of Health","source_url":"https://profiles.mountsinai.org/judith-a-aberg","status":"verified","collected_at":"2026-10-26"},{"value":"Dr. George Baehr Professor of Clinical Medicine (endowed professorship, Icahn School of Medicine at Mount Sinai)","source_url":"https://profiles.mountsinai.org/judith-a-aberg","status":"verified","collected_at":"2026-10-26"}]}},"similar":[{"name":"Deepak Bhatt","slug":"deepak-bhatt","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/deepak-bhatt","json_url":"https://www.findmykol.com/kol/deepak-bhatt/profile.json"},{"name":"Gregg Stone","slug":"gregg-stone","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/gregg-stone","json_url":"https://www.findmykol.com/kol/gregg-stone/profile.json"},{"name":"Jonathan Halperin","slug":"jonathan-halperin","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/jonathan-halperin","json_url":"https://www.findmykol.com/kol/jonathan-halperin/profile.json"},{"name":"Donna Mancini","slug":"donna-mancini","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/donna-mancini","json_url":"https://www.findmykol.com/kol/donna-mancini/profile.json"},{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"},{"name":"Myron Cohen","slug":"myron-cohen","institution":"University of North Carolina at Chapel Hill School of Medicine","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/myron-cohen","json_url":"https://www.findmykol.com/kol/myron-cohen/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":8,"payments":11,"funding":98,"publications":23,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-26"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-26"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-26"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2019},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-26"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-26"}},"methodology_url":"https://www.findmykol.com/about#methodology"}